TY - JOUR
T1 - Molecular signature in HCV-positive lymphomas
AU - De Re, Valli
AU - Caggiari, Laura
AU - Garziera, Marica
AU - De Zorzi, Mariangela
AU - Repetto, Ombretta
PY - 2012
Y1 - 2012
N2 - Hepatitis C virus (HCV) is a positive, single-stranded RNA virus, which has been associated to different subtypes of B-cell non-Hodgkin lymphoma (B-NHL). Cumulative evidence suggests an HCV-related antigen driven process in the B-NHL development. The underlying molecular signature associated to HCV-related B-NHL has to date remained obscure. In this review, we discuss the recent developments in this field with a special mention to different sets of genes whose expression is associated with BCR coupled to Blys signaling which in turn was found to be linked to B-cell maturation stages and NF-κb transcription factor. Even if recent progress on HCV-B-NHL signature has been made, the precise relationship between HCV and lymphoma development and phenotype signature remain to be clarified.
AB - Hepatitis C virus (HCV) is a positive, single-stranded RNA virus, which has been associated to different subtypes of B-cell non-Hodgkin lymphoma (B-NHL). Cumulative evidence suggests an HCV-related antigen driven process in the B-NHL development. The underlying molecular signature associated to HCV-related B-NHL has to date remained obscure. In this review, we discuss the recent developments in this field with a special mention to different sets of genes whose expression is associated with BCR coupled to Blys signaling which in turn was found to be linked to B-cell maturation stages and NF-κb transcription factor. Even if recent progress on HCV-B-NHL signature has been made, the precise relationship between HCV and lymphoma development and phenotype signature remain to be clarified.
UR - http://www.scopus.com/inward/record.url?scp=84866168937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84866168937&partnerID=8YFLogxK
U2 - 10.1155/2012/623465
DO - 10.1155/2012/623465
M3 - Article
C2 - 22952554
AN - SCOPUS:84866168937
VL - 2012
JO - Clinical and Developmental Immunology
JF - Clinical and Developmental Immunology
SN - 1740-2522
M1 - 623465
ER -